BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27720232)

  • 1. Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?
    Barrington DA; Dilley SE; Landers EE; Thomas ED; Boone JD; Straughn JM; McGwin G; Leath CA
    Gynecol Oncol; 2016 Dec; 143(3):617-621. PubMed ID: 27720232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
    In Choi J; Chang HK; Lee DW; Lee KH; Park JS; Lee HN
    Gynecol Oncol; 2015 Nov; 139(2):319-23. PubMed ID: 26360017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
    Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
    Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study.
    Waggoner SE; Darcy KM; Fuhrman B; Parham G; Lucci J; Monk BJ; Moore DH;
    Gynecol Oncol; 2006 Dec; 103(3):853-8. PubMed ID: 16815535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
    Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
    Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
    Rauh LA; Saks EJ; Nakad-Rodriguez D; Showalter TN; Duska LR
    Gynecol Oncol; 2018 Aug; 150(2):338-342. PubMed ID: 29935911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of uterine corpus tumor invasion in early-stage cervical cancer.
    Matsuo K; Machida H; Blake EA; Takiuchi T; Mikami M; Roman LD
    Eur J Surg Oncol; 2017 Apr; 43(4):725-734. PubMed ID: 28215507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical Cancer in Women Aged 35 Years and Younger.
    Pelkofski E; Stine J; Wages NA; Gehrig PA; Kim KH; Cantrell LA
    Clin Ther; 2016 Mar; 38(3):459-66. PubMed ID: 26899314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
    Hanprasertpong J; Jiamset I; Atjimakul T
    Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer.
    Grover S; Showalter S; Kraft KH; Suneja G; Lin L
    Int J Gynecol Cancer; 2013 Mar; 23(3):494-9. PubMed ID: 23388613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-recurrence survival in patients with cervical cancer.
    Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
    Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution in the management of locally advanced cervical cancer: the experience of Cancer Institute (WIA), Chennai, India.
    Shanta V; Selvaluxmy G; Swaminathan R; Shanthi P
    Asian Pac J Cancer Prev; 2010; 11(4):1091-8. PubMed ID: 21133630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Wu X
    Int J Gynecol Cancer; 2019 Oct; 29(8):1244-1251. PubMed ID: 31422351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
    DeBoer RJ; Umutoni V; Bazzett-Matabele L; Katznelson E; Nguyen C; Umwizerwa A; Bigirimana JB; Paciorek A; Nsabimana N; Ruhangaza D; Ntasumbumuyange D; Shulman LN; Triedman SA; Shyirambere C
    Gynecol Oncol; 2022 Feb; 164(2):370-378. PubMed ID: 34916066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.
    Yin KC; Lu CH; Lin JC; Hsu CY; Wang L
    J Formos Med Assoc; 2018 Oct; 117(10):922-931. PubMed ID: 30025761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.